社区获得性肺炎治疗合理性的回顾性分析
|
摘要
目的分析社区获得性肺炎(community-acquired pneumonia,CAP)患者在昆明医学院第二附属医院呼吸科的治疗情况,阐明CAP治疗的合理性问题。方法以2002年01月01日至2006年12月31日在昆明医学院第二附属医院呼吸科住院的417例CAP患者为研究对象,通过回顾性研究,应用SPSS13.0统计分析软件,分析患者的住院情况、首剂抗生素使用情况、痰培养阳性率及病死率,了解我科CAP患者的治疗情况并进一步了解我国CAP指南在我科的执行情况。结果1、(1)按我国CAP病情评估标准,我科社区获得性肺炎符合住院标准患者为80.6%,不符合住院标准患者为19.4%,与Fine评分之间无统计学差别(P=0.094);(2)2002年～2006年入院治疗符合率之间无统计学差异(P=0.473);2、(1)平均住院时间(15±10)天,与薛晓艳研究组的(14±6)天无差别(F=5.02,P＞0.05);(2)5年的平均住院时间未见明显变化(F=1.958,P=0.1)。3、痰培养的阳性率为12.8%。肺炎链球菌是最常见的病原菌,占47%。4、(1)2002年～2006年首剂抗生素治疗除2例外,均在诊断为CAP后4小时以内;(2)首剂抗生素治疗选择中β-内酰胺类抗生素使用居第一位(64.8%),其次为喹诺酮类(17.3%)、林可霉素类(8.6%)、大环内酯类(5.0%)。在联合用药方面,头孢类药物与其他类药物联合居首位(92.3%);(3)2002年～2006年首剂抗生素的使用遵循我国CAP诊疗指南的为68.8%(287/417),5年的年遵循率未见明显变化(P=0.577);(4)首剂抗生素治疗失败87例(20.86%),其中β-内酰胺类抗生素的使用占79.31%。①首剂抗生素失败率最高的是头孢类联合喹诺酮类,其余依次为β-内酰胺类、头孢类联合大环内酯类、林可霉素类、喹诺酮类、大环内酯类。通过x~2检验,P=0.064,说明各类首剂抗生素治疗的失败率之间无差别。②87例患者中,首剂抗生素选择未遵循指南者37例。首剂抗生素选择遵循指南者50例,其中14例治疗失败原因不明,其余36例治疗失败与病情重(PSI＞130分)、年龄≥65岁及痰培养出CAP非常见病原菌有关。③5年间首剂抗生素治疗的失败率未见明显变化(P=0.913);(5)死亡39例,β-内酰胺类为其常用的首剂抗生素。①首剂抗生素治疗的病死率,以喹诺酮类最低;②5年的病死率为9.4%(39/417),并且5年的病死率未见明显变化(P=0.624);③首剂抗生素选择遵循指南的病死率为4.9%(14/287),未遵循指南的病死率为19.2%(25/130),后者的病死率明显高于前者(P=0.000);结论1、根据我国CAP病情评估标准及PSI标准,住院CAP患者中有19.42%～30.0%的患者可以安全接受门诊治疗,从而造成医疗资源的浪费。2、我科痰培养结果阳性率12.8%,以肺炎链球菌、流感嗜血杆菌为主。虽然阳性率低于国内的其他地区,但细菌的分布相似。非典型病原体抗体的检测有待开展。3、我科CAP患者平均住院时间(15±10)天,与国内报道相似。4、我科CAP治疗首剂抗生素选择以β-内酰胺类抗生素居首位,其次为喹诺酮类;在联合用药方面,也以β-内酰胺类联合喹诺酮类为主。5、我科首剂抗生素选择遵循指南的患者占68.8%(287/417),首剂抗生素治疗失败率20.86%(87/287),其中遵循指南治疗的失败率为17.42%(50/287),未遵循指南治疗的失败率为28.46%(37/130),通过x~2检验,P=0.013,表明遵循指南选择首剂抗生素治疗能够降低失败率。6、我科CAP患者病死率为9.4%(39/417),与国外报道相符。其中首剂抗生素选择遵循指南的患者的病死率为4.9%(14/287),未遵循指南的患者的病死率为19.2%(25/130),通过x~2检验,P=0.000,表明首剂抗生素选择遵循指南能够明显的降低CAP患者的病死率。7、5年间未见指南对患者的治疗(包括治疗地点、住院时间、首剂抗生素使用及治疗情况、病死率)有明显影响。因此,为提高CAP的治疗水平,重视指南、严格遵循指南的意识需进一步增强。
Objective To explore the current therapeutic strategy for community acquired pneumonia(CAP)in the second affiliated hospital of Kunming Medical University,and to illuminate the reasonable therapeutic strategy for CAP.Methods The data of 417 hospitalized CAP patients from January 1 st,2002 to December 31,2006 was documented retrospectively.The patient's situation was scored by either Chinese CAP guideline or Fine's risk classification.The data was analyzed with SPSS 13.0 to identify the patients' hospital situation,the choice of the first dose antibiotics,the positive rate of sputum culture and the mortality,to explore the therapeutic conditions in the department,and in further,to explore the implementation of the Chinese CAP guideline in the department.Results 1(1)According to Chinese CAP guideline,80.6%of the 417 hospitalized CAP patients met the standard and 19.4%didn't meet the standard.There was no significant statistical difference between Chinese CAP guideline and Fine's risk classification(P=0.094).(2)The rate of hospitalization that met the Chinese CAP guideline had no significant statistical difference(P=0.473)in these five years.2(1)The average day of length of stay was(15±10),and there was no significant difference between ours and Xue Xiaoyan'(F=5.02,P＞0.05).(2)The average length of stay did not change obviously in the five years(F=1.958,P=0.1).3 The positive rate of sputum culture was 12.8%.Streptococcus pneumoniae was the most common causative organism,the percentage was 47%.4(1)From the year 2002 to 2006,all the first dose antibiotic treatment was administered within four hours except two.(2)In all the first dose antibiotics,theβ-lactam antibiotics ranked first(64.8%),followed by quinolones(17.3%),Lincomycin category(8.6%),macrolides(5.0%).In combination, Cephalosporin drugs combined with other types of antibiotics ranked first(92.3%).(3) The percentage that the first dose antibiotics used follow the Chinese CAP guideline was 68.8%(287/417).There was no significant difference in the percentage in five years(P=0.577).(4)The first dose antibiotic treatment was failed in 87 cases(20.86%), and among all the first dose antibiotics that were used in these 87 cases,β-lactam antibiotics accounted for 79.31%.①The treatment failure rate was the highest when the first dose antibiotic was cephalosporins plus quinolones,and followed byβ-lactams, cephalosporins plus macrolides,lincomycin,quinolones,macrolides.Through chi square test,P=0.064,it meaned that there was no difference among the various types of antibiotic in the treatment failure rate.②In 87 cases,the cases that the first dose antibiotics didn't follow the Chinese CAP guideline was 37,50 cases followed.Among the 50 cases,the reason was unknown in 14 cases,the remaining 36 cases were related with the severity of the illnesses、age≥65y and atypical pathogens seen in the sputum culture.③There was no significant difference among the failure rate of the first dose antibiotic treatment(P=0.913).(5)The death cases was 39,and among all the first dose antibiotics that were used in these 39 cases,β-lactam antibiotics was the most common.①The mortality was the lowest when the first dose antibiotic treatment used quinolones.②The mortality was 9.4%(39/417)in five years,and there was no significant difference in mortality in five years(P=0.624).③The mortality was 4.9%(14/287)when the first dose antibiotics used follow the Chinese CAP guideline, and the mortality was 19.2%(25/130)when didn't,the latter was obviously higher than the former(P=0.000).Conclusions 1 According to Chinese CAP guideline and PSI standards,some patients(19.42%～30.0%)could be safely treated as out-patients,and this condition results in the waste of medical resources.2 The positive rate of sputum culture was 12.8%,Streptococcus pneumoniae and Haemophilus influenzae were the common pathogens.Though the positive rate was lower than other regions in China,but the distribution of bacteria was similar with the other regions.Atypical pathogens antibody testing need to be undertaken.3 The average day of length of stay was(15±10),and it was similar with other reports in domestic.4 In all the first dose antibiotics, theβ-lactam antibiotics ranked first,followed by quinolones.In combination, Cephalosporin drugs combined with quinolones ranked first.5 The percentage that the first dose antibiotics used follow the Chinese CAP guideline was 68.8%(287/417).The first dose antibiotic treatment failure rate was 20.86%(87/287),and the failure rate was 17.42%(50/287)when the first dose antibiotics used follow the Chinese CAP guideline, and the failure rate was 28.46%(37/130)when didn't,through chi square test,P=0.013, it meaned that the first dose antibiotics used follow the Chinese CAP guideline can reduce the treatment failure rate.6 The mortality was 9.4%(39/417)in five years,and it it was similar with other reports.The mortality was 4.9%(14/287)when the first dose antibiotics used follow Chinese CAP guideline,and the mortality was 19.2%(25/130) when didn't,through chi square test,P=0.000,it meaned that the first dose antibiotics used follow the Chinese CAP guideline can reduce the mortality.7 No significant influence by the Chinese CAP guidelines on the therapy(the site,the length of stay,the mortality,the choice of the first dose antibiotics and its therapeutic conditions)of the CAP patients.Therefore,in order to raise the level of CAP therapy,the consciousness of strictly obey the Chinese CAP guideline for the management of CAP should be strengthened.
Objective To explore the current therapeutic strategy for community acquired pneumonia(CAP)in the second affiliated hospital of Kunming Medical University,and to illuminate the reasonable therapeutic strategy for CAP.Methods The data of 417 hospitalized CAP patients from January 1 st,2002 to December 31,2006 was documented retrospectively.The patient's situation was scored by either Chinese CAP guideline or Fine's risk classification.The data was analyzed with SPSS 13.0 to identify the patients' hospital situation,the choice of the first dose antibiotics,the positive rate of sputum culture and the mortality,to explore the therapeutic conditions in the department,and in further,to explore the implementation of the Chinese CAP guideline in the department.Results 1(1)According to Chinese CAP guideline,80.6%of the 417 hospitalized CAP patients met the standard and 19.4%didn't meet the standard.There was no significant statistical difference between Chinese CAP guideline and Fine's risk classification(P=0.094).(2)The rate of hospitalization that met the Chinese CAP guideline had no significant statistical difference(P=0.473)in these five years.2(1)The average day of length of stay was(15±10),and there was no significant difference between ours and Xue Xiaoyan'(F=5.02,P＞0.05).(2)The average length of stay did not change obviously in the five years(F=1.958,P=0.1).3 The positive rate of sputum culture was 12.8%.Streptococcus pneumoniae was the most common causative organism,the percentage was 47%.4(1)From the year 2002 to 2006,all the first dose antibiotic treatment was administered within four hours except two.(2)In all the first dose antibiotics,theβ-lactam antibiotics ranked first(64.8%),followed by quinolones(17.3%),Lincomycin category(8.6%),macrolides(5.0%).In combination, Cephalosporin drugs combined with other types of antibiotics ranked first(92.3%).(3) The percentage that the first dose antibiotics used follow the Chinese CAP guideline was 68.8%(287/417).There was no significant difference in the percentage in five years(P=0.577).(4)The first dose antibiotic treatment was failed in 87 cases(20.86%), and among all the first dose antibiotics that were used in these 87 cases,β-lactam antibiotics accounted for 79.31%.①The treatment failure rate was the highest when the first dose antibiotic was cephalosporins plus quinolones,and followed byβ-lactams, cephalosporins plus macrolides,lincomycin,quinolones,macrolides.Through chi square test,P=0.064,it meaned that there was no difference among the various types of antibiotic in the treatment failure rate.②In 87 cases,the cases that the first dose antibiotics didn't follow the Chinese CAP guideline was 37,50 cases followed.Among the 50 cases,the reason was unknown in 14 cases,the remaining 36 cases were related with the severity of the illnesses、age≥65y and atypical pathogens seen in the sputum culture.③There was no significant difference among the failure rate of the first dose antibiotic treatment(P=0.913).(5)The death cases was 39,and among all the first dose antibiotics that were used in these 39 cases,β-lactam antibiotics was the most common.①The mortality was the lowest when the first dose antibiotic treatment used quinolones.②The mortality was 9.4%(39/417)in five years,and there was no significant difference in mortality in five years(P=0.624).③The mortality was 4.9%(14/287)when the first dose antibiotics used follow the Chinese CAP guideline, and the mortality was 19.2%(25/130)when didn't,the latter was obviously higher than the former(P=0.000).Conclusions 1 According to Chinese CAP guideline and PSI standards,some patients(19.42%～30.0%)could be safely treated as out-patients,and this condition results in the waste of medical resources.2 The positive rate of sputum culture was 12.8%,Streptococcus pneumoniae and Haemophilus influenzae were the common pathogens.Though the positive rate was lower than other regions in China,but the distribution of bacteria was similar with the other regions.Atypical pathogens antibody testing need to be undertaken.3 The average day of length of stay was(15±10),and it was similar with other reports in domestic.4 In all the first dose antibiotics, theβ-lactam antibiotics ranked first,followed by quinolones.In combination, Cephalosporin drugs combined with quinolones ranked first.5 The percentage that the first dose antibiotics used follow the Chinese CAP guideline was 68.8%(287/417).The first dose antibiotic treatment failure rate was 20.86%(87/287),and the failure rate was 17.42%(50/287)when the first dose antibiotics used follow the Chinese CAP guideline, and the failure rate was 28.46%(37/130)when didn't,through chi square test,P=0.013, it meaned that the first dose antibiotics used follow the Chinese CAP guideline can reduce the treatment failure rate.6 The mortality was 9.4%(39/417)in five years,and it it was similar with other reports.The mortality was 4.9%(14/287)when the first dose antibiotics used follow Chinese CAP guideline,and the mortality was 19.2%(25/130) when didn't,through chi square test,P=0.000,it meaned that the first dose antibiotics used follow the Chinese CAP guideline can reduce the mortality.7 No significant influence by the Chinese CAP guidelines on the therapy(the site,the length of stay,the mortality,the choice of the first dose antibiotics and its therapeutic conditions)of the CAP patients.Therefore,in order to raise the level of CAP therapy,the consciousness of strictly obey the Chinese CAP guideline for the management of CAP should be strengthened.
引文
[1]中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655
[2]中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南(草案)[J].中华结核和呼吸杂志,1999,22(4):199-201
[3]Marrie TJ.Community-acquired pneumonia.Clin.Infect.Dis,1994,18:501-15.
[4]Fine MJ,Auble TE,Yealy DM,Hanusa BH,Weissfeld LA,SingerDE et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-50
[5]薛晓艳,高占成.中国社区获得性肺炎病情评估标准与Fine危险分层的临床对比研究[J].中华结核和呼吸杂志,2002,12:719-722
[6]薛晓艳,高占成,朱继红,等.中国社区获得性肺炎诊断和治疗指南的评价.北京大学学报(医学版),2006;38(3):276-279
[7]Bartolome,M;Almirall,J;Morera,J;et al.A population-based study of the costs of care for community-acquired pneumonia.Eur-Respir-J,2004,23(4):610-6
[8]Suchyta MR,Dean NC,Narus S,et al.Effects of a practice guideline for community-acquired pneumonia in an outpatient setting.Am J Med,2001,110:306-9
[9]Fine MJ,Chowdhry T,Ketema A.Outpatient management of community-acquired pneumonia.Hosp Pract(Off Ed),1998,33:123-33
[10]Marrie TJ,Lau CY,Wheeler Sl,et al.A controlled trial of a critical pathway for treatment of community-acquired pneumonia.JAMA,2000,283:749-55
[11]Patrick W,Hernandez P,Campbell S,et al.Evaluation of a critical pathway for pneumonia performance in a teaching hospital.Am J Resp Crit Care Med,2001,163:A806
[12]S G Campbell,W Patrick,D G Urquhart,et al.Patients with community acquired pneumonia discharged from the emergency department according to a clinical practice guideline.Emerg Med J,2004,21:667-669
[13]李敏,李庆云,罗文侗,等.上海市社区获得性肺炎诊疗现状调查分析[J].上海医学,2003,26(12):871-875
[14]Rosario Menendez,Antoni Torres,Rafael Zalacain,et al.Guidelines for the Treatment of Community-acquired Pneumonia Predictors of Adherence and Outcome.Am J Respir Crit Care Med, 2005,172:757-762
[15]M.Hoogewerf,J.J.Oosterheert,E.Hak,et al.Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia.Clin Microbiol Infect,2006,12:1097-1104
[16]Francisco Arancibia,Santiago Ewig,Jose Antonio Martinez,et al.Antimicrobial Treatment Failures in Patients with Community-acquired Pneumonia Causes and Prognostic Implications.Am J Respir Crit Care Med,2000,162:154-160
[17]Beatriz Roson,Jordi Carratala,Nuna Fernandez Sabe,Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia.Arch Intern Med,2004,164:502-508
[18]D Genne,R Sommer,L Kaiser,et al.Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia.Eur J Clin Microbiol Infect Dis,2006,25:159-166
[19]R Menendez,A Tones,R Zalacain,et al.Risk factors of treatment failure in community acquired pneumonia:implications for disease outcome.Thorax,2004,59:960-965
[20]R.Mene'ndez,D.Ferrando,J.M.Valle's,et al.Initial risk class and length of hospital stay in community-acquired pneumonia.Eur-Respir-J,2001,18(1):151-156
[21]Jose Labarere,Roslyn A.Stone,D Scott Obrosky,etal.Comparison of Outcomes for Low-Risk Outpatients and Inpatients With Pneumonia.Chest,2007,131:480-488
[22]杜娟,高占成.社区获得性肺炎255例治疗与国内外指南推荐方案对比研究[J].中国实用内科杂志,2006,26(3):183-186
[23]Marras TK,Gutierrez C,Chan CK.Appling a prediction rule to identify low-risk patients with community-acquired pneumonia.Chest,2000,118:1339-1343
[24]Fine MJ,Medsger AR,Stone RA,et al.The hospital discharge decision for patients with community-acquired pneumonia.Results from the Pneumonia Patient Outcomes Research Team Cohort Study.Arch Intern Med,1997,157:47-56
[25]Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community2acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754
[26]Richard Wai Wing Lee,Steven Terence Lindstorm.Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.Respirology,2007,12:111-116
[27]David S Battleman,Mark Callahan,Howard T Thaler.Rapid Antibiotic Delivery and Appropriate Antibiotic Selection Reduce Length of Hospital Stay of Patients With Community-Acquired Pneumonia.Arch Intern Med,.2002,162:682-688
[28]Fine MJ,Stone RA,Singer DE,et al.Processes and outcomes of care for patients with community-acquired pneumonia.Results from the Pneumonia Patient Outcomes Research Team (PORT)Cohort Study.Arch Intern Med,1999,159:976-980
[29]Daniel C Malone,Hanan M Shaban.Adherence to ATS Guidelines for Hospitalized Patients with Community-Acquired Pneumonia.Ann Pharmacotherapy,2001,35:1180-1185
[30]谭星宇,何权瀛,赵学红,等.社区获得性肺炎平均住院日影响因素分析.中国卫生统计,2002,19(4):230-231
[31]Laing R,Coles C,Chambers S et al.Community-acquired pneumonia:influence of management practices on length of hospital stay.Intern.Med.J,2004,34:91-7
[32]顾良军,徐允盛.序贯疗法优化抗生素治疗[N].医药经济报,2001-12-7(第3版)
[33]Lionel A Mandell,Richard G Wunderink,Antonio Anzueto,et al.Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults.Clinical Infectious Diseases,2007,44:27-72
[34]Halm EA,Fine MJ,Marrie TJ,et al.Time to clinical stability in patients hospitalized with community-acquired pneumonia:implications for practice guidelines.JAMA,1998,279:1452-1457
[35]Mittl RI,SchwabRJ,Duchin JS,et al.Radiographic resolution of community-acquired pneumonia.Am J Pespir Crit Care Med,1994,149:630-635
[36]Danny McCormick,Michael J.Fine,Christopher M.Coley,et al.Variation in Length of Hospital Stay in Patients with Community-acquired Pneumonia:Are Shorter Stays Associated with Worse Medical Outcomes? Am J Med,1999,107:5-12
[37]Nikole M Scalera,Thomas M File Jr.How long should we treat community-acquired pneumonia.Current Opinion in Infectious Diseases,2007,20:177-181
[38]SkerrettSJ.Diagnostic testing for community-acquired pneumo-nia[J].Clin ChestMed,1999,20:531-548
[39]孙敬,陈会,余理智等.痰液培养定植菌与病原菌判断方法的探讨[J].江西医学检验,2006,24(6):485-488
[40]刘一,何晓峰,刘舸,等.住院的社区获得性肺炎患者病原学多因素分析[J].实用医学杂 志,2006,22(13):1538-1540
[41]刘一,王东,樊再雯,等.社区获得性肺炎病原菌的多因素分析[J].实用心脑肺血管病杂志,2006,14(1):34-36
[42]Lim WS,Macfarlane JT.Study of community acquired pneumonia aetiology(SCAPA)in adults admitted to hospital:implications for management guidelines[J].Thorax,2001,56(4):296-301
[43]李国豪,雷秀霞.痰液常见病原菌培养及抗生素的合理使用.医学文选,2003,22(6):892-894
[44]白庆瑞,郑松柏,许宾.上海市社区获得性肺炎住院患者致病菌及耐药性分析,中国初级卫生保健,2006,20(3):22-25
[45]Bollowa JGM.The reliability of sputum typing and its relation to serum therapy.JAMA,1935,105:1512-1518
[46]吕福祯,多丽波,李家宁,等.哈尔滨地区社区获得性肺炎细菌学检测及临床意义.中国呼吸与危重监护杂志,2003,2:297-299
[47]BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.Thorax,2001,56:1-64
[48]刘又宁,赵铁梅,姚婉贞,等.北京地区成人社区获得性肺炎非典型病原体流行病学调查[J].中华结核和呼吸杂志,2004,27(1):27-30
[49]黄海辉,张婴元,黄绍光,等.上海地区社区获得性肺炎的病原学调查[J].中国抗感染化疗杂志,2003,3(6):321-324
[50]刘又宁,陈民钧,赵铁梅,等.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8
[51]Folke Lagerstrom,Hans Fredlund,Hans Holmberg.Sputum specimens can be obtained from patients with community-acquired pneumonia in primary care.[J].Scand J Prim Health Care,2004,22:83-86
[52]张红璇,廖晓星.社区获得性肺炎患者首剂抗生素治疗地点的对照研究.国际医药卫生导报,2004,10(14):147-149
[53]Christopher Fee,Ellen J.Weber.Idendification of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible.Ann Emerg Med,2007,49:553-559
[54]Steven J.Lawrence,Brooke N.Shadel,Terry L.Leet,et al.An Intervention To Improve Antibiotic Delivery and Sputum Procurement in Patients Hospitalized With Community-Acquired Pneumonia. CHEST, 2002,122:913-919
[55] M M van der Eerden.F Vlaspolder.C S de Graaff,et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.Thaorax, 2005,60:672-678
[56] Huchon GJ, Gialdroni-Grassi G, Leophonte P, et al. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J, 1996,9:1590-5
[57] Giovanni Viegi, Riccardo Pistelli, Mario Cazzola, et al. Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy. Respiratory Medicine, 2006,100:46-55
[58] Bartlett JG,Dowell SF,Mandell LA,File TM Jr,Musher DM,Fine MJ.Guidelines from the Infectious Diseases Society of American. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis, 2000,31:347-82
[59] Beatriz Roson,Jordi Carratala, Nuria Fernandez Sabe,et al. Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia. Arch Intern Med, 2004,164:502-508
[60] Cunha BA, Ortega AM (1995) Antibiotic failure. Med Clin North Am, 79:663-672
[61] Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med ,2000,162:154-60
[62] Fine MJ, Smith MA, Carson CA et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA ,1996,275:134-141
[63] Genne D, Kaiser L, Kinge TN et al (2003) Community acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials. Clin Microb Infect Dis, 9:1-6
[64] Liya Davydov , Steven C. Ebert , Maryann Restino.etal. Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals. Diagnostic Microbiology and Infectious Disease, 2006,54:267-275
[65] Rei Fujiki ,Tomotaka Kawayama.Toshihiko Ueyama,et al. The risk factors for mortality of community-acquired pneumonia in Japan. J Infect Chemother, 2007,13:157-165
[66] R J Boots.J Lipman.R Bellomo,et al. Disease risk and mortality prediction in intensive care patients with pneumonia.Australian and New Zealand Practice in Intensive Care (ANZPIC II). Anaesthesia and Intensive Care, 2004,33:101-111
[67]龙怀聪,肖邦榕,刘跃建,等.重症肺炎死亡危险因素分析[J].实用医院临床杂志,2007,4(1):38-40
[68]尹代江,黄丽兰,汤雪容.社区获得性肺炎转归及其影响因素[J].贵州医药2004,28(8):757-759
[69]Kahn KL,Rogers WH,Rubenstein LV,et al.Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system..JAMA,1990,264:1969-1973
[70]McGarvey R.N,Harper JJ.Pneumonia mortality reduction and quality improvement in a community hospital.QRB Qual Rev Bull,1993,19:124-130
[71]Meehan TP,Fine MJ,Krumholz HM,et al.Quality of care,process and outcomes in elderly patients with pneumonia.JAMA,1997,278:2080-2084
[72]Peter M.Houck,Dale W.Bratzler,DO,Wato Nsa,et al.Timing of Antibiotic Administration and Outcomes for Medicare Patients Hospitalized With Community-Acquired Pneumonia.Arch Intern Med,2004,164:637-644
[73]American Thoracic Society.Guidelines for the initial management of adults with community-acquired pneumonia:diagnosis,assessment of severity and initial antimicrobial therapy.Am J Respir Crit Care Med,1993,148:1418-1426
[74]Rosario Menendez,Antoni Torres,Rafael Zalacain,et al.Guidelines for the Treatment of Community-acquired Pneumonia Predictors of Adherence and Outcome.Am J Respir Crit Care Med,2005,172:757-762
[75]Dean NC,Silver MP,Bateman KA,James B,Hadlock CJ,Hale D.Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia.Am J Med,2001,110:451-457
[76]Dudas V,Hopefl A,Jacobs R,Guglielmo BJ.Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia:a survey of nonteaching US community hospitals.Ann Pharmacother,2000,34:446-452
[77]Menendez R,Ferrando D,Valles JM,Vallterra J.Influence of deviation from guidelines on the outcome of community-acquired pneumonia.Chest,2002,122:612-617
[78]Mortensen EM,Restrepo M,Anzueto A,Pugh J.Effects of guidelineconcordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.Am J Med,2004, 117:726-731
[79]Doern GV,Heilmann KP,Huyuh HK,et al.Antimicrobial resistance among clinical isolates of streptococcus pneumonia in the United States during 1999-2000,including a comparison of resistance rates since 1994-1995[J].Antimicrob Agents Chemther,2001,45:1721-1729
[80]任小红,朱海利,易银沙,等.营养支持疗法在婴幼儿重症肺炎转归中的作用[J].中南大学学报(医学版),2005,30(6):711-713
[81]Fisman DN,Abrutyn E,Spaude KA,et al.Prior pneumococcal vaccination is associated with reduced death,complications,and length of stay among hospitalized adults with community-acquired pneumonia.Clin Infect Dis,2006,42:1093-1101
[82]Christenson B,Hedlund J,Lundbergh P,et al.Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.Eur Respir J,2004,23:363-368
[83]Gross PA,Hermogenes AW,Sacks HS,Lau J,Levandowski RA.The efficacy of influenza vaccine in elderly persons:a meta-analysis and review of the literature.Ann Intern Med,1995,123:518-527
[84]Wilde JA,McMillan JA,Serwint J,Butta J,O'Riordan MA,Steinhoff MC.Effectiveness of influenza vaccine in health care professionals:a randomized trial.JAMA,1999,281:908-913
[85]Bridges CB,Thompson WW,Meltzer MI,et al.Effectiveness and cost-benefit of influenza vaccination of healthy working adults:a randomized controlled trial.JAMA,2000,284:1655-1663
[86]Kimberly A.Spaude,MPH;Elias Abrutyn,MD;Cheryl Kirchner,RN,MS;et al.Influenza Vaccination and Risk of Mortality Among Adults Hospitalized With Community-Acquired Pneumonia.Arch Intern Med,2007,167:53-59
[1]中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655
[2]MacFarlance JT.Community-acquired pneumonia.Br J Dis Chest,1987,811:116-127
[3]Woodhead MA,MacFarlance JT.McCracken JS,et al.Prospective study of the etiology and outcome of pneumonia in the pneumonia in the community.Lancet,1987,1:671-674
[4]Jokinen C,Heiskanen L,Juvonen H,et al.Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland.Am J Epidemiol,1993,137:977-990
[5]Foy HM,Cooney MK,Allan I,et al.Rates of pneumonia during influenza epidemics in Seattle,1964 to 1975.JAMA,1979,241:253-258
[6]Arnold FW,Ramirez JA,McDonald LC,et al.Hospitalization for community-acquired pneumonia:the pneumonia severity in-dex vs clinical judgment.Chest,2003,124:121-124
[7]Marrie TJ.Community-acquired pneumonia.Clin.Infect,Dis,1994,18:501-15
[8]Fine MJ,Chowdhry T,Ketema A.Outpatient management of community-acquired pneumonia.Hosp Pract(Off Ed),1998,33:123-133
[9]Meehan TP,Fine MJ,Krumholz HM,Scinto JD,Galusha DH,Mockalis JT,Weber GF,Petrillo MK,Houck PM,Fine JM:Quality of care,process,and outcomes in elderly patients with pneumonia.JAMA,1997,278:2080-2084
[10]Ramirez JA:Community-acquired pneumonia in adults.Prim Care,2003,30:155-171
[11]Espana PP,Capelastegui A,Quintana JM,et al.A prediction role to identify allocation of inpatient care in community-acquired pneumonia.Eur Respir J,2003,21:695-701
[12]Hagberg L,Carbon C,van Rensburg DJ,et al.Telithromycin in the treatment of community-acquired pneumonia:a pooled analysis.Respir Med,2003,97:625-633
[13]Garbino J,Sommer R,Gerber A,et al.:Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland.Int J Infect Dis,2002,6:288-293
[14]徐凯峰,柳涛,高瑞通.成人社区获得性肺炎诊治进展.中华内科杂志,2002,41(5):348
[15]Marrie TJ.Community-acquired pneumonia.Clin Infect Dis,1994,18:501-513
[16]Metaly JP,Schulz R,Li Y-H,et al.Influence of age on symptoms at presentation in patients with community-acquired pneumonia.Arch Intern Med,1997,157:1453-1459
[17]McFadden JP,Eastwood HD,Briggs RS,et al.Raised respiratory rate in elderly patients:a valuable physical sign.Br Med J,1982,284:626-627
[18]Speets AM,Hoes AW,Van der Graaf Y,et al.Chest radiography and pneumonia in primary care:diagnostic yield and consequences for patient management.Eur Respir J,2006,28:933-938
[19]Hannu Syrjala,Markku Broas,Ilkka Suramo,et al.High-resolution computed tomography for the diagnosis of community-acquired pneumonia.Clin Infect Dis,1998,27:358-363
[20]Bartlett JG,Doweli SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Clin Infect Dis,2000,31:347-382
[21]Beat Muller,Stephan Harbarth,Daiana Stolz,et al.Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.BMC Infectious Diseases,2007,7:10
[22]Steven J.Lawrence,Brooke N.Shadel,Terry L.Leet,et al.An Intervention To Improve Antibiotic Delivery and Sputum Procurement in Patients Hospitalized With Community-Acquired Pneumonia.CHEST,2002,122:913-919
[23]Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumoni-a.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754
[24]BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.Thorax,2001,56:1-64
[25]Gomez J,Banos V,Ruiz Gomez J,et al.Prospective study of epidemiology and prognostic factors in community-aequired pneumonia.Eur J Clin Microbiol Infec Dis,1996,15:556-560
[26]Tortes A,El Ebiary M,Riquelme R,et al.Community-acquired pneumonia in the elderly.Semin Respir Infect,1999,14:173-183
[27]Higuera F,Hidalgo H,Feris J,et al.Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.J Antimicrob Chemother,1996,37:555-564
[28]Bollowa JGM.The reliability of sputum typing and its relation to serum therapy.JAMA,1935,105:1512-1518
[29]吕福祯,多丽波,李家宁,等.哈尔滨地区社区获得性肺炎细菌学检测及临床意义.中国呼吸与危重监护杂志,2003,2:297-299
[30]Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology (SCAPA)in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301
[31]ZALACAIN R,TORRES A,CELLS R,et al.Comunity-acquired pneumonia in the elderly:Spanish multicentre study[J].J Eur Respir,2003,21(2):294-302
[32]黄海辉,张婴元,黄绍光,等.上海地区社区获得性肺炎的病原学调查[J].中国抗感染化疗染志,2003,3(6):321-324
[33]刘又宁,陈民钧,赵铁梅,等.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8
[34]Bartlett JG,Breiman RF,Mandell LA,et all Community-acquired pneumonia in adults:guidelines for management.The Infectious Diseases Society of Americal Clin Infect Dis,1998,26:811-838
[35]Muder RR,Yu VL,Fang GD.Community-acquired Legionnaires disease.Semin Respir Infect,1989,4:32-39
[36]Hammerschlag MR.Community-acquired pneumonia due to atypical organisms in adults: diagnosis and treatement.Infect Dis Clin Pract,1999,8:232-240
[37]刘又宁,赵铁梅,姚婉贞,等.北京地区成人社区获得性肺炎非典型病原体流行病学调查[J].中华结核和呼吸杂志,2004,27(1):27-30
[38]黄海辉,张婴元,黄绍光,等.上海地区社区获得性肺炎的病原学调查[J].中国抗感染化疗杂志,2003,3(6):321-324
[39]胡云建,张秀珍.非典型病原体引起呼吸道感染的调查.中华医学感染学杂志,2002,12:580
[40]Luna CM,Videla A,Mattera J,et al.Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia.Chest,1999,116:1075
[41]Garbino J,Sommer R,Gerber A,et al.Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland.Int J Infect Dis,2002,6:288-293
[42]Oosterheert JJ,Bonten MJ,Hak E,et al.Severe community-acquired pneumonia:what's in a name? Curr Opin Infect Dis 2003,16:153-I59.
[43]Fernandez-Sabe N,Carratala J,Dorca J,et al.Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections.Eur J Clin Microbiol Infect Dis,2003,22:185-187
[44]Pimentel LP,McPherson SJ.Community-acquired pneumonia in the emergency department:a practical approach to diagnosis and management.Emerg Med Clin North Am,2003,1:395-420
[45]Andrews J,Nadjm B,Gant V,et al.Community-acquired pneumonia.Curr Opin Pulm Med,2003,9:175-180
[46]R.Menendez,D.Ferrando,J.M.Valles,et al.Initial risk class and length of hospital stay in community-acquired pneumonia.Eur-Respir-J,2001,18(1):151-6
[47]Bartolome,-M;Almira1l,-J;Morera,-J;et al.A population-based study of the costs of care for community-acquired pneumonia.Eur-Respir-J,2004,23(4):610-6
[48]薛晓艳.高占成,朱继红,等.中国社区获得性肺炎诊断和治疗指南的评价.北京大学学报(医学版),2006,38(3):276-279
[49]Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-25
[50]American College of Emergency Physicians.Clinical policy for the management and risk stratifications of community-acquired pneumonia in adults in the emergency department.Ann Emerg Med,2001,38:107-11
[51]Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the CanadianThoracic Society.The Canadian Community-Acquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421
[52]薛晓艳,高占成.中国社区获得性肺炎病情评估标准与Fine危险分层的临床对比研究.中华结核和呼吸杂志,2002,25:719-722
[53] Jose Labarere, Roslyn A. Stone, D. Scott Obrosky, et al. Comparison of Outcomes for Low-Risk Outpatients and Inpatients With Pneumonia A Propensity-Adjusted Analysis. Chest, 2007, 131:480-488
[54] Lionel A Mandell, Richard G Wunderink, Antonio Anzueto, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases, 2007,44:27-72
[55] Marras TK, Gutierrez C, Chan CK. Appling a prediction rule to identify low-risk patients with community-acquired pneumonia. Chest, 2000,118: 1339-1343
[56] Kahn KL, Rogers WH, Rubenstein LV, et al. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system.. JAMA, 1990,264:1969-1973
[57] McGarvey RN, Harper JJ. Pneumonia mortality reduction and quality improvement in a community hospital. QRB Qual Rev Bull, 1993,19:124-130
[58] Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process and outcomes in elderly patients with pneumonia. JAMA, 1997,278:2080-2084
[59] Peter M. Houck, Dale W. Bratzler, DO, Wato Nsa, et al. Timing of Antibiotic Administration and Outcomes for Medicare Patients Hospitalized With Community-Acquired Pneumonia. Arch Intern Med, 2004,164:637-644
[60] Mittl RI, SchwabRJ, Duchin JS, et al.Radiographic resolution of community-acquired pneumonia.Am J Pespir Crit Care Med, 1994,149:630-635
[61] Butler JC, Freiman RF, Campbell JF, et al. Polysaecharide pneumococcal vaccine efficacy: an evaluation of current recommendations. JAMA, 1993,270:1826-1831
[62] Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. New Engl J Med, 2003, 348:1747-1755
[63] Fisman DN, Abrutyn E, Spaude KA, et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis, 2006, 42: 1093-1101
[64] Christenson B, Hedlund J, Lundbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J, 2004, 23: 363-368
[65] Ramirez JA: Community-acquired pneumonia in adults. Prim Care, 2003, 30: 155-171
[66] Niederman MS, Ahmed QA: Community-acquired pneumonia in elderly patients. Clin Geriatr Med, 2003, 19:101-120
[2]中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南(草案)[J].中华结核和呼吸杂志,1999,22(4):199-201
[3]Marrie TJ.Community-acquired pneumonia.Clin.Infect.Dis,1994,18:501-15.
[4]Fine MJ,Auble TE,Yealy DM,Hanusa BH,Weissfeld LA,SingerDE et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-50
[5]薛晓艳,高占成.中国社区获得性肺炎病情评估标准与Fine危险分层的临床对比研究[J].中华结核和呼吸杂志,2002,12:719-722
[6]薛晓艳,高占成,朱继红,等.中国社区获得性肺炎诊断和治疗指南的评价.北京大学学报(医学版),2006;38(3):276-279
[7]Bartolome,M;Almirall,J;Morera,J;et al.A population-based study of the costs of care for community-acquired pneumonia.Eur-Respir-J,2004,23(4):610-6
[8]Suchyta MR,Dean NC,Narus S,et al.Effects of a practice guideline for community-acquired pneumonia in an outpatient setting.Am J Med,2001,110:306-9
[9]Fine MJ,Chowdhry T,Ketema A.Outpatient management of community-acquired pneumonia.Hosp Pract(Off Ed),1998,33:123-33
[10]Marrie TJ,Lau CY,Wheeler Sl,et al.A controlled trial of a critical pathway for treatment of community-acquired pneumonia.JAMA,2000,283:749-55
[11]Patrick W,Hernandez P,Campbell S,et al.Evaluation of a critical pathway for pneumonia performance in a teaching hospital.Am J Resp Crit Care Med,2001,163:A806
[12]S G Campbell,W Patrick,D G Urquhart,et al.Patients with community acquired pneumonia discharged from the emergency department according to a clinical practice guideline.Emerg Med J,2004,21:667-669
[13]李敏,李庆云,罗文侗,等.上海市社区获得性肺炎诊疗现状调查分析[J].上海医学,2003,26(12):871-875
[14]Rosario Menendez,Antoni Torres,Rafael Zalacain,et al.Guidelines for the Treatment of Community-acquired Pneumonia Predictors of Adherence and Outcome.Am J Respir Crit Care Med, 2005,172:757-762
[15]M.Hoogewerf,J.J.Oosterheert,E.Hak,et al.Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia.Clin Microbiol Infect,2006,12:1097-1104
[16]Francisco Arancibia,Santiago Ewig,Jose Antonio Martinez,et al.Antimicrobial Treatment Failures in Patients with Community-acquired Pneumonia Causes and Prognostic Implications.Am J Respir Crit Care Med,2000,162:154-160
[17]Beatriz Roson,Jordi Carratala,Nuna Fernandez Sabe,Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia.Arch Intern Med,2004,164:502-508
[18]D Genne,R Sommer,L Kaiser,et al.Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia.Eur J Clin Microbiol Infect Dis,2006,25:159-166
[19]R Menendez,A Tones,R Zalacain,et al.Risk factors of treatment failure in community acquired pneumonia:implications for disease outcome.Thorax,2004,59:960-965
[20]R.Mene'ndez,D.Ferrando,J.M.Valle's,et al.Initial risk class and length of hospital stay in community-acquired pneumonia.Eur-Respir-J,2001,18(1):151-156
[21]Jose Labarere,Roslyn A.Stone,D Scott Obrosky,etal.Comparison of Outcomes for Low-Risk Outpatients and Inpatients With Pneumonia.Chest,2007,131:480-488
[22]杜娟,高占成.社区获得性肺炎255例治疗与国内外指南推荐方案对比研究[J].中国实用内科杂志,2006,26(3):183-186
[23]Marras TK,Gutierrez C,Chan CK.Appling a prediction rule to identify low-risk patients with community-acquired pneumonia.Chest,2000,118:1339-1343
[24]Fine MJ,Medsger AR,Stone RA,et al.The hospital discharge decision for patients with community-acquired pneumonia.Results from the Pneumonia Patient Outcomes Research Team Cohort Study.Arch Intern Med,1997,157:47-56
[25]Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community2acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754
[26]Richard Wai Wing Lee,Steven Terence Lindstorm.Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.Respirology,2007,12:111-116
[27]David S Battleman,Mark Callahan,Howard T Thaler.Rapid Antibiotic Delivery and Appropriate Antibiotic Selection Reduce Length of Hospital Stay of Patients With Community-Acquired Pneumonia.Arch Intern Med,.2002,162:682-688
[28]Fine MJ,Stone RA,Singer DE,et al.Processes and outcomes of care for patients with community-acquired pneumonia.Results from the Pneumonia Patient Outcomes Research Team (PORT)Cohort Study.Arch Intern Med,1999,159:976-980
[29]Daniel C Malone,Hanan M Shaban.Adherence to ATS Guidelines for Hospitalized Patients with Community-Acquired Pneumonia.Ann Pharmacotherapy,2001,35:1180-1185
[30]谭星宇,何权瀛,赵学红,等.社区获得性肺炎平均住院日影响因素分析.中国卫生统计,2002,19(4):230-231
[31]Laing R,Coles C,Chambers S et al.Community-acquired pneumonia:influence of management practices on length of hospital stay.Intern.Med.J,2004,34:91-7
[32]顾良军,徐允盛.序贯疗法优化抗生素治疗[N].医药经济报,2001-12-7(第3版)
[33]Lionel A Mandell,Richard G Wunderink,Antonio Anzueto,et al.Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults.Clinical Infectious Diseases,2007,44:27-72
[34]Halm EA,Fine MJ,Marrie TJ,et al.Time to clinical stability in patients hospitalized with community-acquired pneumonia:implications for practice guidelines.JAMA,1998,279:1452-1457
[35]Mittl RI,SchwabRJ,Duchin JS,et al.Radiographic resolution of community-acquired pneumonia.Am J Pespir Crit Care Med,1994,149:630-635
[36]Danny McCormick,Michael J.Fine,Christopher M.Coley,et al.Variation in Length of Hospital Stay in Patients with Community-acquired Pneumonia:Are Shorter Stays Associated with Worse Medical Outcomes? Am J Med,1999,107:5-12
[37]Nikole M Scalera,Thomas M File Jr.How long should we treat community-acquired pneumonia.Current Opinion in Infectious Diseases,2007,20:177-181
[38]SkerrettSJ.Diagnostic testing for community-acquired pneumo-nia[J].Clin ChestMed,1999,20:531-548
[39]孙敬,陈会,余理智等.痰液培养定植菌与病原菌判断方法的探讨[J].江西医学检验,2006,24(6):485-488
[40]刘一,何晓峰,刘舸,等.住院的社区获得性肺炎患者病原学多因素分析[J].实用医学杂 志,2006,22(13):1538-1540
[41]刘一,王东,樊再雯,等.社区获得性肺炎病原菌的多因素分析[J].实用心脑肺血管病杂志,2006,14(1):34-36
[42]Lim WS,Macfarlane JT.Study of community acquired pneumonia aetiology(SCAPA)in adults admitted to hospital:implications for management guidelines[J].Thorax,2001,56(4):296-301
[43]李国豪,雷秀霞.痰液常见病原菌培养及抗生素的合理使用.医学文选,2003,22(6):892-894
[44]白庆瑞,郑松柏,许宾.上海市社区获得性肺炎住院患者致病菌及耐药性分析,中国初级卫生保健,2006,20(3):22-25
[45]Bollowa JGM.The reliability of sputum typing and its relation to serum therapy.JAMA,1935,105:1512-1518
[46]吕福祯,多丽波,李家宁,等.哈尔滨地区社区获得性肺炎细菌学检测及临床意义.中国呼吸与危重监护杂志,2003,2:297-299
[47]BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.Thorax,2001,56:1-64
[48]刘又宁,赵铁梅,姚婉贞,等.北京地区成人社区获得性肺炎非典型病原体流行病学调查[J].中华结核和呼吸杂志,2004,27(1):27-30
[49]黄海辉,张婴元,黄绍光,等.上海地区社区获得性肺炎的病原学调查[J].中国抗感染化疗杂志,2003,3(6):321-324
[50]刘又宁,陈民钧,赵铁梅,等.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8
[51]Folke Lagerstrom,Hans Fredlund,Hans Holmberg.Sputum specimens can be obtained from patients with community-acquired pneumonia in primary care.[J].Scand J Prim Health Care,2004,22:83-86
[52]张红璇,廖晓星.社区获得性肺炎患者首剂抗生素治疗地点的对照研究.国际医药卫生导报,2004,10(14):147-149
[53]Christopher Fee,Ellen J.Weber.Idendification of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible.Ann Emerg Med,2007,49:553-559
[54]Steven J.Lawrence,Brooke N.Shadel,Terry L.Leet,et al.An Intervention To Improve Antibiotic Delivery and Sputum Procurement in Patients Hospitalized With Community-Acquired Pneumonia. CHEST, 2002,122:913-919
[55] M M van der Eerden.F Vlaspolder.C S de Graaff,et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.Thaorax, 2005,60:672-678
[56] Huchon GJ, Gialdroni-Grassi G, Leophonte P, et al. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J, 1996,9:1590-5
[57] Giovanni Viegi, Riccardo Pistelli, Mario Cazzola, et al. Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy. Respiratory Medicine, 2006,100:46-55
[58] Bartlett JG,Dowell SF,Mandell LA,File TM Jr,Musher DM,Fine MJ.Guidelines from the Infectious Diseases Society of American. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis, 2000,31:347-82
[59] Beatriz Roson,Jordi Carratala, Nuria Fernandez Sabe,et al. Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia. Arch Intern Med, 2004,164:502-508
[60] Cunha BA, Ortega AM (1995) Antibiotic failure. Med Clin North Am, 79:663-672
[61] Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med ,2000,162:154-60
[62] Fine MJ, Smith MA, Carson CA et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA ,1996,275:134-141
[63] Genne D, Kaiser L, Kinge TN et al (2003) Community acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials. Clin Microb Infect Dis, 9:1-6
[64] Liya Davydov , Steven C. Ebert , Maryann Restino.etal. Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals. Diagnostic Microbiology and Infectious Disease, 2006,54:267-275
[65] Rei Fujiki ,Tomotaka Kawayama.Toshihiko Ueyama,et al. The risk factors for mortality of community-acquired pneumonia in Japan. J Infect Chemother, 2007,13:157-165
[66] R J Boots.J Lipman.R Bellomo,et al. Disease risk and mortality prediction in intensive care patients with pneumonia.Australian and New Zealand Practice in Intensive Care (ANZPIC II). Anaesthesia and Intensive Care, 2004,33:101-111
[67]龙怀聪,肖邦榕,刘跃建,等.重症肺炎死亡危险因素分析[J].实用医院临床杂志,2007,4(1):38-40
[68]尹代江,黄丽兰,汤雪容.社区获得性肺炎转归及其影响因素[J].贵州医药2004,28(8):757-759
[69]Kahn KL,Rogers WH,Rubenstein LV,et al.Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system..JAMA,1990,264:1969-1973
[70]McGarvey R.N,Harper JJ.Pneumonia mortality reduction and quality improvement in a community hospital.QRB Qual Rev Bull,1993,19:124-130
[71]Meehan TP,Fine MJ,Krumholz HM,et al.Quality of care,process and outcomes in elderly patients with pneumonia.JAMA,1997,278:2080-2084
[72]Peter M.Houck,Dale W.Bratzler,DO,Wato Nsa,et al.Timing of Antibiotic Administration and Outcomes for Medicare Patients Hospitalized With Community-Acquired Pneumonia.Arch Intern Med,2004,164:637-644
[73]American Thoracic Society.Guidelines for the initial management of adults with community-acquired pneumonia:diagnosis,assessment of severity and initial antimicrobial therapy.Am J Respir Crit Care Med,1993,148:1418-1426
[74]Rosario Menendez,Antoni Torres,Rafael Zalacain,et al.Guidelines for the Treatment of Community-acquired Pneumonia Predictors of Adherence and Outcome.Am J Respir Crit Care Med,2005,172:757-762
[75]Dean NC,Silver MP,Bateman KA,James B,Hadlock CJ,Hale D.Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia.Am J Med,2001,110:451-457
[76]Dudas V,Hopefl A,Jacobs R,Guglielmo BJ.Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia:a survey of nonteaching US community hospitals.Ann Pharmacother,2000,34:446-452
[77]Menendez R,Ferrando D,Valles JM,Vallterra J.Influence of deviation from guidelines on the outcome of community-acquired pneumonia.Chest,2002,122:612-617
[78]Mortensen EM,Restrepo M,Anzueto A,Pugh J.Effects of guidelineconcordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.Am J Med,2004, 117:726-731
[79]Doern GV,Heilmann KP,Huyuh HK,et al.Antimicrobial resistance among clinical isolates of streptococcus pneumonia in the United States during 1999-2000,including a comparison of resistance rates since 1994-1995[J].Antimicrob Agents Chemther,2001,45:1721-1729
[80]任小红,朱海利,易银沙,等.营养支持疗法在婴幼儿重症肺炎转归中的作用[J].中南大学学报(医学版),2005,30(6):711-713
[81]Fisman DN,Abrutyn E,Spaude KA,et al.Prior pneumococcal vaccination is associated with reduced death,complications,and length of stay among hospitalized adults with community-acquired pneumonia.Clin Infect Dis,2006,42:1093-1101
[82]Christenson B,Hedlund J,Lundbergh P,et al.Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.Eur Respir J,2004,23:363-368
[83]Gross PA,Hermogenes AW,Sacks HS,Lau J,Levandowski RA.The efficacy of influenza vaccine in elderly persons:a meta-analysis and review of the literature.Ann Intern Med,1995,123:518-527
[84]Wilde JA,McMillan JA,Serwint J,Butta J,O'Riordan MA,Steinhoff MC.Effectiveness of influenza vaccine in health care professionals:a randomized trial.JAMA,1999,281:908-913
[85]Bridges CB,Thompson WW,Meltzer MI,et al.Effectiveness and cost-benefit of influenza vaccination of healthy working adults:a randomized controlled trial.JAMA,2000,284:1655-1663
[86]Kimberly A.Spaude,MPH;Elias Abrutyn,MD;Cheryl Kirchner,RN,MS;et al.Influenza Vaccination and Risk of Mortality Among Adults Hospitalized With Community-Acquired Pneumonia.Arch Intern Med,2007,167:53-59
[1]中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655
[2]MacFarlance JT.Community-acquired pneumonia.Br J Dis Chest,1987,811:116-127
[3]Woodhead MA,MacFarlance JT.McCracken JS,et al.Prospective study of the etiology and outcome of pneumonia in the pneumonia in the community.Lancet,1987,1:671-674
[4]Jokinen C,Heiskanen L,Juvonen H,et al.Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland.Am J Epidemiol,1993,137:977-990
[5]Foy HM,Cooney MK,Allan I,et al.Rates of pneumonia during influenza epidemics in Seattle,1964 to 1975.JAMA,1979,241:253-258
[6]Arnold FW,Ramirez JA,McDonald LC,et al.Hospitalization for community-acquired pneumonia:the pneumonia severity in-dex vs clinical judgment.Chest,2003,124:121-124
[7]Marrie TJ.Community-acquired pneumonia.Clin.Infect,Dis,1994,18:501-15
[8]Fine MJ,Chowdhry T,Ketema A.Outpatient management of community-acquired pneumonia.Hosp Pract(Off Ed),1998,33:123-133
[9]Meehan TP,Fine MJ,Krumholz HM,Scinto JD,Galusha DH,Mockalis JT,Weber GF,Petrillo MK,Houck PM,Fine JM:Quality of care,process,and outcomes in elderly patients with pneumonia.JAMA,1997,278:2080-2084
[10]Ramirez JA:Community-acquired pneumonia in adults.Prim Care,2003,30:155-171
[11]Espana PP,Capelastegui A,Quintana JM,et al.A prediction role to identify allocation of inpatient care in community-acquired pneumonia.Eur Respir J,2003,21:695-701
[12]Hagberg L,Carbon C,van Rensburg DJ,et al.Telithromycin in the treatment of community-acquired pneumonia:a pooled analysis.Respir Med,2003,97:625-633
[13]Garbino J,Sommer R,Gerber A,et al.:Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland.Int J Infect Dis,2002,6:288-293
[14]徐凯峰,柳涛,高瑞通.成人社区获得性肺炎诊治进展.中华内科杂志,2002,41(5):348
[15]Marrie TJ.Community-acquired pneumonia.Clin Infect Dis,1994,18:501-513
[16]Metaly JP,Schulz R,Li Y-H,et al.Influence of age on symptoms at presentation in patients with community-acquired pneumonia.Arch Intern Med,1997,157:1453-1459
[17]McFadden JP,Eastwood HD,Briggs RS,et al.Raised respiratory rate in elderly patients:a valuable physical sign.Br Med J,1982,284:626-627
[18]Speets AM,Hoes AW,Van der Graaf Y,et al.Chest radiography and pneumonia in primary care:diagnostic yield and consequences for patient management.Eur Respir J,2006,28:933-938
[19]Hannu Syrjala,Markku Broas,Ilkka Suramo,et al.High-resolution computed tomography for the diagnosis of community-acquired pneumonia.Clin Infect Dis,1998,27:358-363
[20]Bartlett JG,Doweli SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Clin Infect Dis,2000,31:347-382
[21]Beat Muller,Stephan Harbarth,Daiana Stolz,et al.Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.BMC Infectious Diseases,2007,7:10
[22]Steven J.Lawrence,Brooke N.Shadel,Terry L.Leet,et al.An Intervention To Improve Antibiotic Delivery and Sputum Procurement in Patients Hospitalized With Community-Acquired Pneumonia.CHEST,2002,122:913-919
[23]Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumoni-a.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754
[24]BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.Thorax,2001,56:1-64
[25]Gomez J,Banos V,Ruiz Gomez J,et al.Prospective study of epidemiology and prognostic factors in community-aequired pneumonia.Eur J Clin Microbiol Infec Dis,1996,15:556-560
[26]Tortes A,El Ebiary M,Riquelme R,et al.Community-acquired pneumonia in the elderly.Semin Respir Infect,1999,14:173-183
[27]Higuera F,Hidalgo H,Feris J,et al.Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.J Antimicrob Chemother,1996,37:555-564
[28]Bollowa JGM.The reliability of sputum typing and its relation to serum therapy.JAMA,1935,105:1512-1518
[29]吕福祯,多丽波,李家宁,等.哈尔滨地区社区获得性肺炎细菌学检测及临床意义.中国呼吸与危重监护杂志,2003,2:297-299
[30]Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology (SCAPA)in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301
[31]ZALACAIN R,TORRES A,CELLS R,et al.Comunity-acquired pneumonia in the elderly:Spanish multicentre study[J].J Eur Respir,2003,21(2):294-302
[32]黄海辉,张婴元,黄绍光,等.上海地区社区获得性肺炎的病原学调查[J].中国抗感染化疗染志,2003,3(6):321-324
[33]刘又宁,陈民钧,赵铁梅,等.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8
[34]Bartlett JG,Breiman RF,Mandell LA,et all Community-acquired pneumonia in adults:guidelines for management.The Infectious Diseases Society of Americal Clin Infect Dis,1998,26:811-838
[35]Muder RR,Yu VL,Fang GD.Community-acquired Legionnaires disease.Semin Respir Infect,1989,4:32-39
[36]Hammerschlag MR.Community-acquired pneumonia due to atypical organisms in adults: diagnosis and treatement.Infect Dis Clin Pract,1999,8:232-240
[37]刘又宁,赵铁梅,姚婉贞,等.北京地区成人社区获得性肺炎非典型病原体流行病学调查[J].中华结核和呼吸杂志,2004,27(1):27-30
[38]黄海辉,张婴元,黄绍光,等.上海地区社区获得性肺炎的病原学调查[J].中国抗感染化疗杂志,2003,3(6):321-324
[39]胡云建,张秀珍.非典型病原体引起呼吸道感染的调查.中华医学感染学杂志,2002,12:580
[40]Luna CM,Videla A,Mattera J,et al.Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia.Chest,1999,116:1075
[41]Garbino J,Sommer R,Gerber A,et al.Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland.Int J Infect Dis,2002,6:288-293
[42]Oosterheert JJ,Bonten MJ,Hak E,et al.Severe community-acquired pneumonia:what's in a name? Curr Opin Infect Dis 2003,16:153-I59.
[43]Fernandez-Sabe N,Carratala J,Dorca J,et al.Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections.Eur J Clin Microbiol Infect Dis,2003,22:185-187
[44]Pimentel LP,McPherson SJ.Community-acquired pneumonia in the emergency department:a practical approach to diagnosis and management.Emerg Med Clin North Am,2003,1:395-420
[45]Andrews J,Nadjm B,Gant V,et al.Community-acquired pneumonia.Curr Opin Pulm Med,2003,9:175-180
[46]R.Menendez,D.Ferrando,J.M.Valles,et al.Initial risk class and length of hospital stay in community-acquired pneumonia.Eur-Respir-J,2001,18(1):151-6
[47]Bartolome,-M;Almira1l,-J;Morera,-J;et al.A population-based study of the costs of care for community-acquired pneumonia.Eur-Respir-J,2004,23(4):610-6
[48]薛晓艳.高占成,朱继红,等.中国社区获得性肺炎诊断和治疗指南的评价.北京大学学报(医学版),2006,38(3):276-279
[49]Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-25
[50]American College of Emergency Physicians.Clinical policy for the management and risk stratifications of community-acquired pneumonia in adults in the emergency department.Ann Emerg Med,2001,38:107-11
[51]Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the CanadianThoracic Society.The Canadian Community-Acquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421
[52]薛晓艳,高占成.中国社区获得性肺炎病情评估标准与Fine危险分层的临床对比研究.中华结核和呼吸杂志,2002,25:719-722
[53] Jose Labarere, Roslyn A. Stone, D. Scott Obrosky, et al. Comparison of Outcomes for Low-Risk Outpatients and Inpatients With Pneumonia A Propensity-Adjusted Analysis. Chest, 2007, 131:480-488
[54] Lionel A Mandell, Richard G Wunderink, Antonio Anzueto, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases, 2007,44:27-72
[55] Marras TK, Gutierrez C, Chan CK. Appling a prediction rule to identify low-risk patients with community-acquired pneumonia. Chest, 2000,118: 1339-1343
[56] Kahn KL, Rogers WH, Rubenstein LV, et al. Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system.. JAMA, 1990,264:1969-1973
[57] McGarvey RN, Harper JJ. Pneumonia mortality reduction and quality improvement in a community hospital. QRB Qual Rev Bull, 1993,19:124-130
[58] Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process and outcomes in elderly patients with pneumonia. JAMA, 1997,278:2080-2084
[59] Peter M. Houck, Dale W. Bratzler, DO, Wato Nsa, et al. Timing of Antibiotic Administration and Outcomes for Medicare Patients Hospitalized With Community-Acquired Pneumonia. Arch Intern Med, 2004,164:637-644
[60] Mittl RI, SchwabRJ, Duchin JS, et al.Radiographic resolution of community-acquired pneumonia.Am J Pespir Crit Care Med, 1994,149:630-635
[61] Butler JC, Freiman RF, Campbell JF, et al. Polysaecharide pneumococcal vaccine efficacy: an evaluation of current recommendations. JAMA, 1993,270:1826-1831
[62] Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. New Engl J Med, 2003, 348:1747-1755
[63] Fisman DN, Abrutyn E, Spaude KA, et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis, 2006, 42: 1093-1101
[64] Christenson B, Hedlund J, Lundbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J, 2004, 23: 363-368
[65] Ramirez JA: Community-acquired pneumonia in adults. Prim Care, 2003, 30: 155-171
[66] Niederman MS, Ahmed QA: Community-acquired pneumonia in elderly patients. Clin Geriatr Med, 2003, 19:101-120